trending Market Intelligence /marketintelligence/en/news-insights/trending/zewm-a-ctly1ysvelohrqg2 content esgSubNav
In This List

Sinovac Biotech extends termination date of going-private deal

Video

S&P Capital IQ Pro | Powering Your Edge

Video

S&P Capital IQ Pro | Unrivaled Sector Coverage

Blog

Enterprises are missing out on 24B by not optimizing cloud spending not going multicloud

Blog

Investment Research Analysts Providing Greater Coverage on Inflation


Sinovac Biotech extends termination date of going-private deal

Sinovac Biotech Ltd. extended the termination date of its going-private deal to April 26.

The original termination date was March 26.

The Beijing-based biopharmaceutical company agreed to go private in a $400 million transaction in June 2017. The transaction initially was expected to close in the second half of 2017.